Breaking News
Close
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Pfizer Inc (PFE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pfizer's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
52.31 -0.12    -0.23%
01/07 - Closed. Currency in USD ( Disclaimer )
After Hours
52.28
-0.03
-0.06%
0:59:10 - Real-time Data
  • Volume: 16,056,730
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 51.25 - 52.37
Type:  Equity
Market:  United States
ISIN:  US7170811035 
CUSIP:  717081103
Pfizer 52.31 -0.12 -0.23%
  • General    
  • Chart    
  • News & Analysis    
  • Financials    
  • Technical    
  • Forum    
  • InvestingPro

PFE Financial Summary

 
See below for an overview of the Pfizer financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

For the three months ended 03 April 2022, Pfizer Inc. revenues increased 77% to $25.66B. Net income applicable to common stockholders excluding extraordinary items increased 61% to $7.87B. Revenues reflect Vaccines-Comimaty direct sales and alliance revenues segment increase from $3.46B to $13.23B, Hospital-Paxlovid segment increase from $0K to $1.47B, Developed Europe segment increase from $2.82B to $7.37B.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

PFE Income Statement

Gross margin TTM 60.45%
Operating margin TTM 30.32%
Net Profit margin TTM 27.56%
Return on Investment TTM 18.43%
 Total Revenue  Net Income
Period Ending: Apr 03, 2022 Dec 31, 2021 Oct 03, 2021 Jul 04, 2021
Total Revenue 25661 23635 24094 18977
Gross Profit 15651 14024 14169 11991
Operating Income 9873 4576 7647 5914
Net Income 7863 3393 8146 5564

PFE Balance Sheet

Quick Ratio MRQ 1.13
Current Ratio MRQ 1.39
LT Debt to Equity MRQ 43.26%
Total Debt to Equity MRQ 44.04%
 Total Assets  Total Liabilities
Period Ending: Apr 03, 2022 Dec 31, 2021 Oct 03, 2021 Jul 04, 2021
Total Assets 183841 181476 179188 169920
Total Liabilities 101417 104276 103496 99878
Total Equity 82424 77200 75692 70042

PFE Cash Flow Statement

Cash Flow/Share TTM 5.34
Revenue/Share TTM 16.11
Operating Cash Flow  16.66%
 Cash  Net Change in Cash
Period Ending: Apr 03, 2022 Dec 31, 2021 Oct 03, 2021 Jul 04, 2021
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 6541 32580 26666 15836
Cash From Investing Activities 567 -22546 -19960 -9884
Cash From Financing Activities -6578 -9816 -6465 -5364
Net Change in Cash 529 159 209 593
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lee Baldwin
Lee Baldwin Mar 31, 2022 13:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Great long term er at this price
Reply
1 0
Report
Death Revenge
Death Revenge Feb 19, 2022 22:30
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
please never effective.inbox me for fast rising stocks
Reply
0 0
Report
Trevor Uren
Trevor Uren Feb 14, 2022 15:19
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Adverse Effects Rife
Reply
1 0
Report
Ali Atat
Ali Atat Jan 20, 2022 8:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No logic for drop. This is a 60 Euro stock value
Reply
9 0
Report
Michael Potts
Michael Potts Jan 20, 2022 8:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It will drop like a stone, when the FDA release the data.
Reply
0 0
Report
Andrew Lees
Andrew Lees Jan 06, 2022 7:13
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
Reply
2 4
Report
Timor Malul
Timor Malul Jan 05, 2022 15:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
Reply
4 0
Report
Basil Skater
Basil Skater Dec 17, 2021 16:28
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why TF is this not rising ?
Reply
2 0
Report
Andrzej Bagiński
Andrzej Bagiński Nov 19, 2021 17:11
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
Reply
1 0
Report
ifigeneia ifigeneia
ifigeneia ifigeneia Nov 07, 2021 4:57
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Rumors says Albert have been arrested this Friday is it true or fraud? Anybody knows?
Reply
0 7
Report
hope meng
hope meng Oct 29, 2021 10:32
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
cathy wood favourite...
Reply
0 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Investing.com
Our Apps
DOWNLOAD APPApp store
Investing.com
© 2007-2022 Fusion Media Limited. All Rights Reserved.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
  • Sign up for FREE and get:
  • Real-Time Alerts
  • Advanced Portfolio Features
  • Personalized Charts
  • Fully-Synced App
Continue with Google
or
Sign up with Email